Duration of cardiac effects of timolol and propranolol
- PMID: 4254
- DOI: 10.1002/cpt1976192148
Duration of cardiac effects of timolol and propranolol
Abstract
The duration of the cardiac effects of single intravenous doses of the beta-antagonists, timolol and propranolol, was compared in 6 healthy male subjects. Timolol and propranolol were given in doses of 1 mg and 10 mg, respectively, and at specified times after their administration, beta-blockade was assessed by the reduction of maximal exercise-induced tachycardia and by the inhibition of the chronotropic and inotropic effects of isoproterenol. Inotropic effects were measured by changes in the pre-ejection period of left ventricular systole obtained from systolic time intervals. There was no statistically significant difference in the timolol and propranolol time-courses of beta-blockade. The change in exercise-tachycardia was maximal 5 min after beta-antagonist infusion but dissipated rapidly so that no statistically significant change was observed 9 hr later. The chronotropic and inotropic effects of isoproterenol were almost completely antagonized for 11/2 hr after beta-antagonist infusion, and significant beta-blockade could be demonstrated 9 hr later. There was no difference in the time-course of the negative chronotropic and inotropic effects of either beta-antagonist.
Similar articles
-
Comparison of cardiac effects of timolol and propranolol.Clin Pharmacol Ther. 1975 Sep;18(3):278-86. doi: 10.1002/cpt1975183278. Clin Pharmacol Ther. 1975. PMID: 1100298 Clinical Trial.
-
Comparison of the inotropic and chronotropic effects of metoprolol and propranolol.J Clin Pharmacol. 1981 May-Jun;21(5-6):213-8. doi: 10.1002/j.1552-4604.1981.tb02550.x. J Clin Pharmacol. 1981. PMID: 7263914
-
Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.Eur J Clin Pharmacol. 1978 Nov 9;14(1):7-14. doi: 10.1007/BF00560252. Eur J Clin Pharmacol. 1978. PMID: 32043
-
Timolol maleate, a new beta-adrenergic receptor blocking agent.Arch Int Pharmacodyn Ther. 1975 Feb;213(2):251-63. Arch Int Pharmacodyn Ther. 1975. PMID: 238479
-
Cardiovascular and beta-adrenergic blocking effects of timolol.Eur J Pharmacol. 1976 Feb;35(2):235-43. doi: 10.1016/0014-2999(76)90225-9. Eur J Pharmacol. 1976. PMID: 2481
Cited by
-
The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies.Br J Clin Pharmacol. 2020 Feb;86(2):199-209. doi: 10.1111/bcp.14196. Epub 2020 Jan 17. Br J Clin Pharmacol. 2020. PMID: 31833573 Free PMC article. Review.
-
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001. Clin Pharmacokinet. 1976. PMID: 13958 Review.
-
Efficacy of low-dose 90Sr-90Y therapy combined with topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas.Exp Ther Med. 2015 Sep;10(3):1013-1018. doi: 10.3892/etm.2015.2609. Epub 2015 Jul 1. Exp Ther Med. 2015. PMID: 26622431 Free PMC article.
-
Plasma timolol levels after oral and intravenous administration.Eur J Clin Pharmacol. 1978 Dec 18;14(6):431-4. doi: 10.1007/BF00716385. Eur J Clin Pharmacol. 1978. PMID: 738350
-
Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.Br J Clin Pharmacol. 1982 Nov;14(5):719-25. doi: 10.1111/j.1365-2125.1982.tb04963.x. Br J Clin Pharmacol. 1982. PMID: 6128021 Free PMC article. Clinical Trial.